ABSTRACT
Objectives To assess the association between use of adaptive pacing on clinical and economic outcomes of CRT recipients in real-world analysis.
Background The AdaptivCRTTM algorithm was shown in prior subgroup analyses of prospective trials to achieve clinical benefits, but a large prospective trial showed nonsignificant changes in the endpoint of mortality or heart failure hospitalizations.
Methods CRT-implanted patients from the Optum Clinformatics® database with ≥90 days of follow-up were included. Remote monitoring data was used to classify patients based on CRT setting – adaptive biventricular and left ventricular pacing (aCRT) vs. standard biventricular pacing (Standard CRT). Inverse probability of treatment weighting was used to adjust for baseline differences between groups. Mortality, 30-day readmissions, healthcare utilization, and payer and patient costs were evaluated post-implantation.
Results This study included 2,412 aCRT and 1,638 Standard CRT patients (mean follow-up: 2.4 ± 1.4 years), with balanced baseline characteristics after adjustment. The aCRT group was associated with lower all-cause mortality (adjusted hazard ratio = 0.88 [95% confidence interval (CI):0.80, 0.96]), fewer all-cause 30-day readmissions (adjusted incidence rate ratio = 0.87 [CI:0.81, 0.94]), and fewer all-cause and HF-related inpatient, outpatient, and emergency department (ED) visits. The aCRT cohort was also associated with lower all-cause outpatient payer-paid amounts and lower all-cause and HF-related inpatient and ED patient-paid amounts.
Conclusions In this retrospective analysis of a large real-world cohort, use of an adaptive CRT algorithm was associated with lower mortality, reduced healthcare resource utilization, and lower payer and patient costs.
Competing Interest Statement
Dr. Gold has clinical trial support and consulting fees from Medtronic and Boston Scientific. Dr. Chung has clinical trial support and consulting fees from Medtronic and Abbott. JZ, LH, and DL are current Medtronic employees and minority shareholders.
Clinical Trial
Since this study used only retrospective data sources, clinical trial disclosure was not applicable.
Funding Statement
This study was supported by Medtronic, plc.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was deemed exempt from review, because this study used only de-identified administrative claims and did not meet the definition of human subject research.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The Optum Clinformatics database is available for purchase through Optum. However, the Optum Clinformatics database linked with Medtronic device registry data is only available to Medtronic personnel.
ABBREVIATION LIST
- aCRT
- Adaptive CRT
- aIRR
- Adjusted Incidence Rate Ratio
- AV
- Atrio-ventricular
- BiV
- Biventricular
- CDM
- Clinformatics® Data Mart
- CI
- Confidence intervals
- CRT
- Cardiac resynchronization therapy
- HF
- Heart failure
- HR
- Hazard ratio
- HRU
- Healthcare resource utilization
- ICD
- Implantable cardioverter defibrillator
- ICD-9-CM
- The International Classification of Disease, Ninth Revision, Clinical Modification
- ICD-10-CM
- The International Classification of Disease, Tenth Revision, Clinical Modification
- IPTW
- Inverse probability of treatment weighting
- IRR
- Incidence rate ratio
- LBBB
- Left bundle branch block
- LV
- Left ventricular
- PS
- Propensity score
- SMD
- Standardized mean difference
